Close Menu

In a YouTube animation, user JavaMama926 depicts hypothetical conversation between an investigator and a biostatistician and says that "this is what happens when two people are speaking different research languages." Watch their expertise and opinions collide — and frustrations emerge — as the researcher approaches the statistician to see whether his proposed patient sample size is adequate for a drug effectiveness trial as his grant deadline looms:

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.